Effect of Sulfonamide Group Modification on Celecoxib: Molecular Features of Matrix Metalloproteinase Interactive UTX-121 Derivative
Anticancer Research · 2025
DOI: 10.21873/anticanres.17706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Kazuto Ohkura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan; kohkura@suzuka-u.ac.jp. Hauptthemen laut MEDLINE: Celecoxib, Matrix Metalloproteinase Inhibitors, Matrix Metalloproteinase 2, Sulfonamides.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan; kohkura@suzuka-u.ac.jp.
- Department of Bioengineering, Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University Graduate School, Tokushima, Japan.
Zitieren
APA
Ohkura, K., Tabata, A., & Uto, Y. (2025). Effect of Sulfonamide Group Modification on Celecoxib: Molecular Features of Matrix Metalloproteinase Interactive UTX-121 Derivative. Anticancer Research. https://doi.org/10.21873/anticanres.17706
Vancouver
Ohkura K, Tabata A, Uto Y. Effect of Sulfonamide Group Modification on Celecoxib: Molecular Features of Matrix Metalloproteinase Interactive UTX-121 Derivative. Anticancer Research. 2025. doi:10.21873/anticanres.17706
BibTeX
@article{Ohkura2025,
author = {Ohkura, Kazuto and Tabata, Atsushi and Uto, Yoshihiro},
title = {Effect of Sulfonamide Group Modification on Celecoxib: Molecular Features of Matrix Metalloproteinase Interactive UTX-121 Derivative},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17706}
}
EUVIMED